Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2013

Aug 27, 2013

34519_dirs_2013-08-27_84a7adfe-755f-44c7-bd11-21a759d1d661.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2013-08-23

Reporting Person: ROTHSCHILD JONATHAN E (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-08-23 Common Stock, par value $0.10 per share P 500 $3.91 Acquired 464280 Direct
2013-08-23 Common Stock, par value $0.10 per share P 500 $4.01 Acquired 464780 Direct
2013-08-23 Common Stock, par value $0.10 per share P 500 $4.01 Acquired 465280 Direct

Footnotes

F1: This figure includes 214,655 shares of common stock held by Arterio Inc., a corporation owned solely by Mr. Rothschild.